Status:

UNKNOWN

Evaluation of the Multidimensional Dyspnea Profile (MDP)

Lead Sponsor:

Institut für Pneumologie Hagen Ambrock eV

Conditions:

COPD Exacerbation

CHF

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Aim of this multicenter prospective cohort study is the evaluation of the multidimensional qualities of dyspnea in a number of diseases using the Multidimensional Dyspnea Profile (Banzett et al, ERJ 2...

Detailed Description

The study sites will examine patients with COPD (Chronic obstructive pulmonary disease) in state of acute exacerbation and in stable state, patients with congestive heart failure (CHF) in state of acu...

Eligibility Criteria

Inclusion

  • COPD patients with acute exacerbation (Group I)
  • CHF patients with acute decompensation (group II)
  • stable COPD patients (group III)
  • OSA patients with AHI\>15 (group IV)

Exclusion

  • Other severe acute diseases that contradict the participation in a clinical trial
  • Simultaneous participation in another clinical trial
  • Not capable of giving consent
  • Language abilities and other disabilities that contradicts the understanding or completing of a clinical questionnaire

Key Trial Info

Start Date :

December 19 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2024

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT04090671

Start Date

December 19 2018

End Date

January 1 2024

Last Update

July 14 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Kliniken Essen-Mitte, Evang. Huyssens-Stiftung/Knappschaft gGmbH

Essen, North Rhine-Westphalia, Germany, 45276

2

Helios Klinik Hagen Ambrock

Hagen, North Rhine-Westphalia, Germany, 58091

3

Märkische Kliniken GmbH, Klinikum Lüdenscheid

Lüdenscheid, North Rhine-Westphalia, Germany, 58515

4

Praxis Dr. med V. Jansen

Menden, North Rhine-Westphalia, Germany, 58706